Lessons from drug allergy: Against dogmata

Current Allergy and Asthma Reports

Volumn 3, Issue 1, 2003, Pages 1-3

  Pichler, Werner J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CARRIER PROTEIN; CD4 ANTIGEN; CD8 ANTIGEN; CELECOXIB; CIPROFLOXACIN; CYTOKINE; GAMMA INTERFERON; HAPTEN; IMMUNOGLOBULIN; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 8; LIDOCAINE; MAJOR HISTOCOMPATIBILITY ANTIGEN; SULFAMETHOXAZOLE;

ANTIGEN ANTIBODY REACTION; ANTIGEN PRESENTING CELL; CELLULAR IMMUNITY; CONTACT DERMATITIS; COVALENT BOND; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG RESPONSE; ERYTHEMA MULTIFORME; GRANULOCYTE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOREACTIVITY; LYMPHOCYTE FUNCTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MEDICAL ERROR; MEDICAL RESEARCH; NOTE; PATHOPHYSIOLOGY; PHYSICIAN ATTITUDE; PREDICTION; PROTEIN TARGETING; SYMPTOMATOLOGY; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; CLINICAL MEDICINE; CROSS REACTION; IMMUNOLOGY; NEUTROPHIL; REVIEW;

CLINICAL MEDICINE; CROSS REACTIONS; CYTOKINES; DRUG HYPERSENSITIVITY; HUMANS; IMMUNITY, CELLULAR; NEUTROPHILS; T-LYMPHOCYTES;

EID: 85047171988     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-003-0001-1     Document Type: Note

References (22)

1. Naisbitt DJ, Gordon SF, Pirmohamed M, Park BK: Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment. Drug Saf 2000, 23:483-507.
2. Griem P, Wulferink M, Sachs B, et al.: Allergic and autoimmune reactions to xenobiotics: how do they arise? Immunol Today 1998, 19:133-141.
3. Cribb AE, Spielberg SP: Sulfamethoxazole is metabolized to the hydroxylamine in humans. Clin Pharmacol Ther 1992, 51:522-526.
4. Schnyder B, Mauri-Hellweg D, Zanni M, et al.: Direct, MHC-dependent presentation of the drug sulfamethoxazole to human T-cell clones. J Clin Invest 1997, 100:136-141.
5. Zanni MP, von Greyerz S, Schnyder B, et al.: HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human ab T lymphocytes. J Clin Invest 1998, 102:1591-1598.
6. Zanni MP, von Greyerz S, Schnyder B, et al.: HLA-unrestricted presentation of lidocaine by HLA-DR molecules to specific ab + T-cell clones. Intern Immunol 1998, 10:507-515.
7. Schnyder B, Burkhard C, Schnyder-Frutig K, et al.: Recognition of sulfamethoxazole and its reactive metabolites by drug specific T cells from allergic individuals. J Immunol 2000, 164:6647-6654.
8. Burkhart C, von Greyerz S, Depta JPH, et al.: Influence of reduced glutathione on the proliferative response of sulfamethoxazole-specific and sulfamethoxazole-metabolite specific human CD4+ T cells. Br J Pharm 2001, 132:623-630.
9. Nassif A, Bensussan A, Dorothée G, et al.: Drug-specific cytotoxic T lymphocytes in the skin lesions of a patient with toxic epidermal necrolysis. J Invest Dermatol 2002, 118:728-733.
10. Sieben J, Kawakubo Y, Masaoudi TA, et al.: Delayed-type hypersensitivity reaction to paraphenylenediamine is mediated by 2 different pathways of antigen recognition by specific ab + human T-cell clones. J Allergy Clin Immunol 2002, 109:1005-1011.
11. Coombs PRA, Gell PGH: Classification of allergic reactions responsible for clinical hypersensitivity and disease. In Clinical Aspects of Immunology Edited by Gell RRA. Oxford: Oxford University Press 1968, 575-596.
12. Mosmann TR, Sad S: The expanding universe of T-cell subsets: Th1, Th2 and more. Immunnol Today 1996, 17:138-146.
13. Higashi N, Bang K, Gesser B, et al.: Cytokine expression of skin T-lymphocytes from patients with atopic dermatitis. Acta Derm Venereol 2001, 81:3-7.
14. Neukomm C, Yawalkar N, Helbling A, Pichler WJ: T-cell reactions to drugs in distinct clinical manifestations of drug allergy. J Invest Allerg Clin Immunol 2001, 11:275-284.
15. Zanni MP, Mauri-Hellweg D, Brander C, et al.: Characterization of lidocaine specific T cells. J Immunol 1997, 158:1139-1148.
16. Britschgi M, Steiner U, Schmid S, et al.: T-cell involvement in drug-induced acute generalized exanthematous pustulosis. J Clin Invest 2001, 11:1433-1441.
17. Yawalkar N, Egli F, Hari Y, et al.: Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions. Clin Exp Allergy 2000, 30:847-855.
18. Schnyder B, Frutig K, Mauri-Hellweg D, et al.: T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazole-induced skin reaction. Clin Exp Allergy 1998, 28:1412-1417.
19. Beylot C, Bioulac P, Doutre MS: Pustuloses exanthématiques aigües généralisées: a propos de 4 cas. Ann Dermatol Venereol 1980, 107:37-48.
20. Roujeau JC, Bioulac-Sage P, Bourseau C: Acute generalized exanthematous pustulosis: analysis of 63 cases. Arch Dermatol 1991, 127:1333-1338.
21. Britschgi M, Pichler WJ: Acute generalized exanthematous pustulosis: a clue to neutrophil-mediated inflammatory processes orchestrated by T cells. Curr Opin Allergy Clin Immunol 2002, 2:325-331.
22. Pichler WJ, Yawalkar N, Schmid S, Helbling A: Pathogenesis of drug-induced exanthema. Allergy 2002, 57:884-893.